Weaning Intraaortic Balloon Counterpulsation: The Evidence by Lewis, Peter & Courtney, Mary
  
 
COVER SHEET 
 
 
This is the author version of article published as: 
 
Lewis, PA and Courtney, M (2006) Weaning intraaortic balloon counterpulsation: the 
evidence. British Journal of Cardiac Nursing 1(8):pp. 385-389. 
Copyright 2006    MA Healthcare 
Accessed from   http://eprints.qut.edu.au 
 
 
 
 
 
 
 
 
 
 
1WEANING INTRAAORTIC BALLOON COUNTERPULSATION: THE 
EVIDENCE
AUTHORS
Peter A Lewis RN RM Cert CC MNed PhD cand 
Senior Lecturer, School of Nursing, Christchurch Polytechnic Institute of 
Technology, Christchurch, New Zealand.
Mary Courtney RN PhD
Director of Research, School of Nursing, Queensland University of 
Technology, Brisbane, Australia.
CORRESPONDING AUTHOR
Peter Lewis
15 Gwynfa Avenue, Cashmere, Christchurch, New Zealand  8002
Phone +64 3 337 9409
2ABSTRACT
The aim of this paper was to determine the most effective manner to wean 
intraaortic balloon counterpulsation (IABP) based on research evidence. An 
exhaustive search of the PubMed, Medline, CINAHL, Cochrane, Science 
Direct and Ovid databases was carried out to source relevant literature. The 
search revealed a paucity of literature related to the cessation of IABP. 
Evidence is unanimous in suggesting the minimization of pharmacological 
assistance before withdrawing any form of mechanical IABP. However, 
opinion related to the direct weaning of IABP by either volume reduction or 
frequency reduction is mixed. The assimilation of IABP studies would imply 
volume reduction weaning to be the most effective method of IABP support 
withdrawal. Volume reduction offers a more physiological approach in 
comparison to frequency reduction weaning, which fails to significantly differ 
from the complete cessation of IABP treatment. When initiating the withdrawal 
of any IABP support, volume reduction should be the method of choice.
3INTRODUCTION
It is necessary to take a number of factors into consideration when weaning 
from intraaortic balloon counterpulsation (IABP). The two main approaches 
are volume reduction weaning or frequency reduction weaning. Because 
frequency reduction weaning can expose the heart to large afterload variance, 
it would appear volume reduction is a more physiologic approach to weaning 
from IABP.
INTRAAORTIC BALLOON COUNTERPULSATION
An intraaortic balloon pump is a device widely used in patients whose cardiac 
function is compromised or potential compromised. IABP requires the 
positioning of an intraaortic balloon catheter in the descending thoracic aorta, 
immediately inferior to the origin of the left subclavian artery and superior to 
the renal arteries (Overwalder, 1999). The catheter is then attached to an 
external pump which will inflate and deflate it in synchrony with the cardiac 
contractions. Balloon inflation occurs at the onset of diastole when blood 
ceases to eject from the heart. Inflation of the catheter results in displacement 
of blood volume within the descending thoracic aorta. Proximal blood is 
returned to the heart to oxygenate the coronary arteries while blood in the 
distal descending aorta is circulated around the body. Catheter deflation is 
timed to occur immediately before the onset of systole and the heart 
commences ejection. This action ensures that afterload is reduced and blood 
is ejected into a partially empty aorta. Cardiac workload and the consequent 
demand for oxygen can thus be reduced. This reduction in afterload also 
4improves cardiac output and increases systemic perfusion (Overwalder, 
1999).
IABP primarily increases myocardial oxygen supply and decreases 
myocardial oxygen demand. In addition, it improves cardiac output, increases 
coronary perfusion pressures, increases systemic perfusion, reduces mitral 
regurgitation and reduces afterload which will subsequently decrease left 
ventricular workload (Bolooki, 1999; Overwalder, 1999). 
The field of IABP has been studied widely and a large number of papers 
concerning best practice, complications, indications and outcome have been 
published (Hanlon-Pena and Pitner, 2000; Cohen et al, 2003; Azeem et al, 
2004; Jafary et al, 2004; Urban et al, 2004; Elahi et al, 2005). However, 
despite extensive research into IABP and the critical condition of patients 
undergoing IABP, few papers specifically address IABP withdrawal. This 
article reviews the current literature relating to the weaning of IABP and 
addresses pharmacological weaning, volume reduction weaning and 
frequency reduction weaning. The aim of this study, through an extensive 
literature review, is to identify the best method to wean IABP. 
SEARCH PROCESS
The PubMed, Medline, CINAHL, Cochrane, Science Direct and Ovid 
databases were used to source literature relating to IABP. The key words 
which were used in the search were IABP, IABC, intraaortic, intra-aortic, 
balloon, pump/ing, counterpulsation, weaning, removal, cardiac; assist, 
5device/s, catheter, and compromise. Combinations of these words were also 
used (e.g. IABP and weaning.) 
AN OVERVIEW OF WEANING
There are a number of factors involved in weaning a patient from IABP. Some 
patients who are undergoing IABP may require respiratory support through 
mechanical ventilation. As a result weaning from IABP principally integrates 
the withdrawal of mechanical support, with a reduction in the patient’s 
pharmacodynamic support through weaning the inotropic, vasopressor and 
vasoactive drugs. Evidence supports the view that pharmacological support 
should be withdrawn before IABP support (Bavin and Self, 1991; Sorrentino 
and Feldman, 1992; Quaal, 1993; Bolooki, 1998; Krau, 1999; Vitale, 1999). 
However, there is a lack of consensus among researchers about the best way 
for withdrawing mechanical support from the drive console. 
The IABP drive console offers the clinician two weaning methods: intraaortic 
balloon catheter volume reduction and intraaortic balloon catheter frequency 
reduction. The available research discusses the current use of both methods, 
either singularly or in conjunction with each other, and the evidence has 
shown success for each variation on weaning (Bavin and Self, 1991; 
Sorrentino and Feldman, 1992; Kantrowitz et al, 1993; Bolooki, 1998; Krau, 
1999).
The withdrawal of mechanical ventilation is equally problematic. Mechanical 
ventilation increases intrathoracic pressure and this in turn places greater 
6force on the heart, thus assisting ejection and lowering the heart’s workload. 
Increased intrathoracic pressures, however, also diminish the filling capacity 
of the heart and consequently reduce cardiac output. Isolated literature 
discusses reducing IABP either before or after extubation (Bolooki, 1984; 
Bolooki, 1998) as well the potential benefit of positive end expiratory pressure 
assisting cardiac ejection fraction (Kontoyannis et al, 1999). 
IABP WEANING TECHNIQUES
Pharmacological reduction weaning 
Whether frequency reduction or volume reduction are used in isolation or in 
various combinations with one another, the weaning process commences with 
the reduction of pharmacological support (Bavin and Self, 1991; Sorrentino 
and Feldman, 1992; Kantrowitz et al, 1993; Bolooki, 1998; Krau, 1999; Vitale, 
1999). A major aim in the management of cardiac failure is the reduction of 
myocardial oxygen consumption. It is also important to reduce afterload which 
decreases the workload of the heart in overcoming the pressure within the 
aorta, thus reducing the myocardial oxygen demand. 
Reducing the level of pharmacological support also decreases cardiac 
workload as drugs such as adrenaline increase the work of the heart. By 
reducing the level of pharmacological support therefore, myocardial oxygen 
demand is also reduced (Vitale, 1999). However, a small amount of 
pharmacological support will provide a cushion should the patient’s condition 
deteriorate after the IABP has been discontinued. If necessary a low level of 
pharmacological assistance can be recommenced and the maximum scope of 
7pharmacological support explored before any other assistance is sought. The 
reinstitution of drugs is an easier, safer and more economical option than the 
reintroduction of IABP (Krau, 1999). However, in cases of leg ischaemia it is 
not advisable to reduce the level of pharmacological support before the 
commencement of volume or frequency weaning. The levels of morbidity 
which are associated with leg ischaemia necessitate either the immediate 
removal of the catheter or a change in insertion site (Bolooki, 1998; Vitale, 
1999).
The inotropic, vasopressor and vasoactive drugs which are used commonly in 
conjunction with IABP therapy include dopamine, dobutamine and 
noradrenaline (Krau, 1999). These particular drugs enhance cardiac rate and 
output, reduce systemic vascular resistance, increase blood pressure and 
increase systemic perfusion (Anon, 2005). When titrating pharmacological 
therapy before commencing volume or frequency weaning, it is initially 
important to move away from more aggressive drugs such as noradrenaline to 
either dopamine or dobutamine (Bolooki, 1998; Krau, 1999). Titration of the 
remaining drugs to a low or minimal dose will naturally follow. Bolooki (1998) 
offers advice on minimal levels of pharmacological support and states that a 
single pressor such as dopamine or dobutamine should not be run at a 
greater rate than than 5 Pg/kg/minute.
Before commencing volume or frequency weaning Bavin and Self (1991) 
taper drugs to relatively low doses until they no longer require frequent 
titration. Kantrowitz (1993) and Krau (1999) meanwhile suggests the complete 
8discontinuation of pharmacological support before any mechanical weaning 
takes place. 
Frequency reduction weaning 
Full IABP assistance consists of the inflation of the intraaortic balloon catheter 
at the onset of diastole after every cardiac contraction. Frequency reduction 
weaning requires a decrease in the total amount of assisted cardiac 
contractions. Assistance is withdrawn on a ratio basis from full assistance of 
1:1 (IABP assistance of every cardiac contraction) to partial assistance (IABP 
assistance less than every cardiac contraction). The initial frequency 
reduction is from 1:1 to 1:2 (IABP assistance of every second cardiac 
contraction). This is followed by the further reduction from 1:2 to 1:4 and in 
some cases a final reduction from 1:4 to 1:8 but not all drive consoles have a 
capacity to pump at a 1:8 ratio. 
A reduction in frequency exposes the heart to large variations in afterload on 
a beat-to-beat basis. As a result this variation has an impact on the amount of 
work the myocardium is expected to perform (Kantrowitz et al, 1993). The 
effectiveness of frequency reduction weaning in the gradual withdrawal of 
cardiac support is questionable and there are no relevant experimental 
studies addressing this issue specifically. 
However, Fuchs et al (1983) have studied a related issue. Their study 
compared the effects of IABP on regional myocardial blood flow in patients 
with unstable angina. Great cardiac vein flow measurements were used as an 
9indicator of the ability of IABP to augment the diastolic perfusion of arteries 
fed by post-stenotic portions of the left anterior descending coronary artery. 
Fuchs found at a frequency of 1:1, IABP increased great cardiac vein flow. He 
also demonstrated that a frequency of 1:1 provided an increase in great 
cardiac vein flow regardless of the intermediate catheter volume (Fuchs et al, 
1983). Assist ratios of less than 1:1, however, led to no increase in great 
cardiac vein flow despite full catheter volume. Furthermore, great cardiac vein 
flow does not significantly differ whether the assist frequency is set to 1:4 or if 
the pump is turned off (Fuchs et al, 1983). 
After studying the haemodynamic data from twelve post-cardiotomy patients, 
Bolooki (1998) suggests that a frequency ratio of 1:3 should be considered as 
balloon ‘off’, and Bavin and Self (1991) assert that a frequency ratio of 1:8 
does nothing more than maintain catheter movement which simply prevents 
thrombus formation. Frequency assistance at a ratio of 1:8 will provide little, if 
any support. It may therefore be suggested that reduced frequency ratios may 
not represent intermediate IABP assistance, but rather the haemodynamic 
equivalent of complete IABP withdrawal. 
Volume reduction weaning 
Volume reduction weaning involves the gradual reduction in the volume of gas 
which inflates the balloon. The drive console allows the clinician to decrease 
the catheter volume in 10% increments from a maximum of 100% to a 
minimum of 0%. While the drive console may allow 10% volume reductions, 
literature discusses a reduction of catheter volume in 20% (Kantrowitz et al, 
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1993; Krau, 1999) or 25% (Bolooki, 1998) increments. However, neither 
Kantrowitz or Bolooki, provide any justification for their chosen volume 
reduction increments. 
In a study by Kantrowitz et al (1993) the catheter volume was reduced in 20% 
increments. With each incremental reducation that level of assistance was 
continued for between and 15 and 30 minutes. If the haemodynamic 
parameters for the patient remained essentially the same, the catheter volume 
could be decreased by a further 20% and the process repeated until the total 
catheter volume is reduced to 20%. 
Larger catheter columes provide a greater degree of cardiovascular support 
and this requires assistance to be continued over a longer timeframe 
(Kantrowitz et al, 1993). Consequently weaning IABP by volume reduction will 
commence slowly and finish more briskly. If a variable haemodynamic 
response is encountered while reducing the catheter volumes, it is necessary 
to proceed weaning with caution. If the patient begins to decompensate and 
his/her haemodyndamic status is such that a cardiac output cannot be 
physiologically maintained, full IABP assistance should be reinstated. Volume 
reduction can be attempted again in a few hours (Kantrowitz et al, 1993). from 
the literature search there was very little information on IABP weaning and 
more specific advice on the length of time that should lapse before trying 
again could not be found. In addition, total catheter volume should not be 
reduced any lower than 20% owing to a high risk of clot formation on the 
surface of the catheter (Kantrowitz et al, 1993; Krau, 1999). 
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Bolooki (1998) suggests a slower and more cautious approach and weaning 
timeframes are based around the duration of IABP therapy. Catheter volume 
is reduced initially to no lower than 50%. A final 25% volume is tested for 10–
15 minutes before the IABP support is discontinued. Bolooki (1998) agrees 
with Kantrowitz et al (1993) in advising the immediate recommencement of 
IABP support if the patient decompensates ans cannot physiologicaaly 
maintain a cardiac output. 
IABP in high risk surgical patients
Past studies demonstrate that if the diastolic pressure is augmented with 
IABP there can be a redistribution of coronary blood flow towards the 
ischaemic areas of the myocardium (Watson et al, 1974; Gill et al, 1975). To 
prevent myocardial ischaemia and possible pre-operative cardiac impairment, 
high risk cardiac surgical patients may require IABP preoperatively. The 
commencement of IABP before anaesthetic will prevent a decrease in 
coronary perfusion pressures which have resulted from a diminished blood 
pressure (Dietl et al, 1996). Considering this and the critical nature of the 
patient’s condition, a reduction in IABP augmentation would appear to be the 
weaning method of choice. Reducing the volume of gas shuttled to the 
catheter inflates it to a lesser extent, thus displacing less aortic blood and 
consequently increasing cardiac afterload. Cardiac workload gradually 
increases in correspondence to the catheter volume making IABP support 
withdrawal a gradual process. This would allow the clinician to make smaller 
support adjustments, better suiting the patient’s requirements. 
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WHAT THE EVIDENCE SUGGESTS
With no direct evidence to suggest that either frequency weaning or volume 
weaning exhibits greater success, both are offered as legitimate options for 
the withdrawal of IABP support (Bavin and Self, 1991; Sorrentino and 
Feldman, 1992; Kantrowitz et al, 1993; Bolooki, 1998; Krau, 1999). It can be 
suggested, however, that frequency reduction may not be as effective as 
volume reduction when weaning IABP. Assist ratios of less than 1:1 fail to 
increase cardiac vein flow (Fuchs and et al, 1983). Additionally, examination 
of haemodynamic outcomes of weaning IABP in heart failure found frequency 
reduction to result in greater haemodynamic suppression when compared 
with volume weaning (O’Malley, 2000). When considering the patient’s 
haemodynamic status, any reduction in intraaortic balloon frequency could be 
the equivalent of complete IABP withdrawal. However, volume weaning may 
be seen as a more physiological approach. The reduction of intraaortic 
balloon catheter volume will gradually increase cardiac workload and it has 
also been demonstrated that larger catheter inflation volumes may further 
augment cardiac output (Cohen et al, 2002). Moreover, diastolic pressures 
augmented with IABP result in the redistribution of coronary blood flow toward 
ischaemic areas of the myocardium (Watson et al, 1974; Gill et al, 1975). 
When these arguments are considered together it may be concluded that 
volume weaning would be the clear method of choice when initiating the 
withdrawal of any IABP support. 
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CONCLUSIONS
Overwhelmingly the literature claims no authority regarding the practice of 
IABP weaning. However, the critical analysis of numerous papers may lead to 
the conclusion that volume reduction weaning is the most effective weaning 
method as frequency reduction weaning appears to be more problematic. 
However, even though frequency reduction weaning involves withdrawing 
IABP support dramatically rather than gradually, it is still used with success 
(Kantrowitz et al, 1993; Krau, 1999). Considering this, a need for the gradual 
withdrawal of IABP support once sufficient cardiac function has been 
demonstrated would appear unwarranted. The reduction of pharmacological 
support provided concomitantly with IABP therapy may be all that is required. 
The popularity of IABP as a treatment for cardiac failure serves only to 
increase the need for a formalized, researched and justified weaning model. 
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KEY POINTS
x Despite extensive research few papers specifically address intraaortic 
balloon counterpulsation withdrawal 
x Pharmacological assistance should be withdrawn prior to a reduction in 
any form of intraaortic balloon counterpulsation support 
x Frequency reduction exposes the heart to large variations in afterload 
on a beat-to-beat basis
x Studies suggest volume reduction weaning to be the most effective 
weaning method
x Volume reduction weaning in comparison to frequency reduction 
weaning is felt to be a more physiologic approach
KEY WORDS 
IABP; assisted circulation; cardiac output, low; weaning. 
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